2020-Borthakur et al-Am J Hematol
"Phase 1 Study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients"
Gautam Borthakur, Zhihong Zeng, Jorge E Cortes, Hsiang-Chun Chen, Xuelin Huang, Marina Konopleva, Farhad Ravandi, Tapan Kadia, Keyur P Patel, Naval Daver, Mary A Kelly, Teresa McQueen, Ru-Yiu Wang, Hagop Kantarjian, Michael Andreeff
Am J Hematol. 2020
https://doi.org/10.1002/ajh.25943
- no dataset accession number given
Gautam Borthakur, Zhihong Zeng, Jorge E Cortes, Hsiang-Chun Chen, Xuelin Huang, Marina Konopleva, Farhad Ravandi, Tapan Kadia, Keyur P Patel, Naval Daver, Mary A Kelly, Teresa McQueen, Ru-Yiu Wang, Hagop Kantarjian, Michael Andreeff
Am J Hematol. 2020
https://doi.org/10.1002/ajh.25943
- no dataset accession number given